Finland is an EU Member State, so medical devices are primarily regulated under the EU MDR/IVDR, alongside national legislation under the Medical Devices Act (719/2021), administered by Fimea. CE marking and national registration requirements must both be addressed before completing Medical Device Registration in Finland.
This article explains Finland Medical Device Regulations , the registration process, notification requirements and ongoing post-market obligations.
Regulatory Authorities for Medical Devices in Finland
Understanding Finland Medical Device Regulatory Requirements means building a compliance approach on two layers. The European Commission sets the EU-wide rules, while Fimea oversees and enforces the applicable requirements within Finland.
Finnish Medicines Agency (Fimea)
Fimea is Finland’s national competent authority for medical devices. It runs the national CERE register, oversees the EUDAMED registration of Finnish operators, receives incident and vigilance reports, supervises manufacturers and other economic operators, and issues classification decisions and derogations under the Medical Devices Act.
Fimea also handles certificates of free sale for export purposes and processes derogation applications for devices that would otherwise need a full conformity assessment. Its role is enforcement and registration within Finland. It does not write the underlying MDR or IVDR rules; that fall under the European Commission and the EU legislature.
European Commission
Both the MDR and IVDR originate at the European Commission.That’s also where EUDAMED sits. EUDAMED is the EU-wide database tracking manufacturers, authorised representatives, importers, devices, notified body certificates and vigilance data.
One more thing worth knowing is the Medical Device Coordination Group (MDCG) operates under the Commission and puts out interpretive guidance, which Fimea and the other national authorities then follow.
Other Finnish Authorities
For most regulatory matters, Fimea is who manufacturers deal with. But customs clearance is a different story. That’s Finnish Customs (Tulli) territory. A device that’s fully MDR-compliant can still sit at the border because of paperwork that has nothing to do with device conformity at all. Two separate systems, running side by side.
Finland Medical Device Classification
Finland follows the EU classification system under the MDR. There is no Finland-only device class.
MDR Annex VIII sets four risk classes:
| Class | Risk Level | Example Devices |
| Class I | Low | Bandages, manual wheelchairs, reusable surgical instruments |
| Class IIa | Low-medium | Hearing aids, dental impression materials |
| Class IIb | Medium-high | Infusion pumps, ventilators |
| Class III | High | Implantable pacemakers, heart valves |
Classification determines almost everything downstream. It decides whether a Notified Body needs to be involved, how much clinical evidence is required, how detailed the technical documentation has to be and what post-market obligations follow once the device is sold. Higher classes mean deeper scrutiny at every later step, including at the Fimea registration stage, since the CERE and EUDAMED notification forms both ask for the device’s risk class.
Fimea also issues formal classification decisions under Article 51 of the MDR when a manufacturer requests one, and under Article 4 of the Act when there’s uncertainty about whether a product qualifies as a medical device at all.This is useful when a product sits in a genuinely grey zone, such as certain software or borderline cosmetic devices.
Authorized Representative (EC REP) Requirements in Finland
A manufacturer based outside the EU must appoint an EU Authorized Representative before placing a device on the EU market, Finland included. This is an EU-level obligation under MDR Article 11.
The Authorized Representative’s core duties, set out in MDR Article 11, include:
- Verifying the EU Declaration of Conformity and technical documentation exist and are current
- Keeping a copy of the technical documentation, the Declaration of Conformity, and, where applicable, the notified body certificate available for authorities
- Forwarding requests from Fimea or other competent authorities to the manufacturer and cooperating on corrective action
- Registering with EUDAMED and being listed as the manufacturer’s representative
A written mandate between the manufacturer and its Authorized Representative is required under MDR Article 11(2).
If the Authorized Representative is established in Finland, it also becomes an operator that Fimea expects to see registered, since authorised representatives established in Finland fall under the categories obliged to notify Fimea. Where the Authorized Representative is established in another EU country, the Finland-specific registration duty generally fall under whichever operator (manufacturer, AR, importer, or distributor) is actually established in Finland, as per the Fimea guidance.
Medical Device Regulations and Guidelines in Finland
No single document covers everything. Manufacturers need to work from a layered set of sources to get the full picture.
At EU level:
- Regulation (EU) 2017/745 (MDR)
- Regulation (EU) 2017/746 (IVDR), where applicable
- MDCG guidance documents
- European Commission medical device guidance pages
At Finnish national level:
- Medical Devices Act (719/2021) – English translation available through Finlex
- Fimea Administrative Regulation 2/2021, which sets out the detail behind Finland’s registration obligations
- Fimea’s published guidance pages on classification, CE marking, labelling and post-market surveillance
Finland isn’t adding extra substance to the MDR itself. What it’s adding is a registration and language layer on top, along with the administrative mechanics of how notifications work, what gets charged, and how inspections run. Anyone relying only on the MDR text and skipping the Medical Devices Act will miss the registration obligation entirely.
Finland Medical Device Registration Process
CE marking and Finnish registration or notification are not automatically the same regulatory action. A device can be lawfully CE marked and still be missing its Fimea notification. Both need to happen.
Step 1: Determine the Device Classification
Confirm the risk class under MDR Annex VIII before any documentation work starts. Getting this wrong early means redoing technical files later.
Step 2: Confirm Applicable EU Regulatory Requirements
Establish that the product meets the MDR definition of a medical device (or the IVDR definition, for in vitro diagnostics) and identify which parts of the Regulation apply to it.
Step 3: Complete the Appropriate Conformity Assessment
Class I devices without a measuring function, sterility requirement or reusable surgical instrument function can generally follow manufacturer self-declaration. Higher classes require Notified Body involvement under MDR Annex IX, X or XI, depending on the chosen route.
Step 4: Prepare Technical Documentation
Build the technical file per MDR Annex II, and the post-market surveillance documentation per Annex III. This is the backbone of every later submission, both to a Notified Body and to Fimea.
Step 5: Complete Clinical Evaluation
Clinical evaluation, governed by MDR Article 61 and Annex XIV, has to demonstrate safety and clinical performance appropriate to the device’s risk class and intended purpose.
Step 6: Establish the Quality Management System
A Quality Management System aligned with MDR Article 10 obligations is required of every manufacturer. ISO 13485 is the standard most manufacturers use to structure this, though it is a tool for demonstrating compliance rather than a legal requirement in itself.
Step 7: Appoint an EU Authorized Representative
Required for manufacturers based outside the EU.
Step 8: Complete Applicable Finnish Registration or Notification
This is where Finland’s national layer becomes active. Before selling, placing on the market, or making a device available in Finland, the responsible operator must notify Fimea of its operations and its devices, either through the national CERE register or through EUDAMED, depending on the operator’s role.
Who registers where is specific:
- Manufacturers, authorised representatives, importers, system or procedure pack assemblers and sterilisers of CE-marked devices, all established in Finland, notify through EUDAMED.
- Manufacturers of custom-made devices (excluding Class III implantables), self-manufacturers inside a health institution and distributors who supply devices to Finnish retailers, healthcare providers or other professional users notify through the national CERE register.
- Not every distributor has to notify. Fimea has stated that distributors are not currently required to submit device notifications until further notice, even though the underlying obligation exists in law.
Registration happens in two stages. The operator registers first and receives an Actor ID/SRN from EUDAMED or a reference number from CERE, then the operator registers its devices under that identifier.
Step 9: Meet Finnish Labeling and Language Requirements
Professional-use instructions can be in Finnish, Swedish or English, while anything necessary for the safe use of a consumer device, including home tests, must be in both Finnish and Swedish.
Step 10: Place the Device on the Finnish Market
Manufacturers and importers are the only operators that legally “place” a device on the market for the first time. Everyone downstream, distributors and end users, receives the device through “making available,” a related but distinct concept under MDR.
Step 11: Maintain Post-Market Surveillance and Vigilance
PMS and vigilance obligations start once the device is on the market and continue for as long as it stays there.
Documentation Requirements for Medical Devices in Finland
Not every document goes to Fimea. Some prove MDR conformity and stay in the manufacturer’s files; others get submitted as part of a Fimea or EUDAMED notification; a third group simply needs to be available on request.
Documents that demonstrate MDR conformity (retained by the manufacturer):
- EU Declaration of Conformity (MDR Articles 10 and 19)
- Technical documentation (MDR Annex II)
- Post-market surveillance documentation (MDR Annex III)
- Clinical Evaluation Report
- Risk management file
- Notified Body certificate, where applicable
Information submitted to Fimea or EUDAMED as part of registration:
- Operator identity and role (manufacturer, AR, importer, distributor, and so on)
- Device information tied to the operator’s Actor ID/SRN or CERE reference number
- Classification details
Documents that must be available to authorities on request, without automatic submission:
- Authorized Representative mandate
- Full technical file, if Fimea requests it during supervision or an inspection
Do not assume every item on this list must be filed directly with Fimea. Registration notifications record operator and device information; they are not a wholesale submission of the technical file.
QMS Requirements for Medical Devices in Finland
Finland does not run a separate national Quality Management System (QMS) scheme for MDR-regulated devices. Manufacturer QMS obligations come from MDR Article 10, which requires a system covering risk management, design and development controls, supplier oversight, production controls, complaint handling, corrective and preventive action, and post-market surveillance.
ISO 13485 is the standard most manufacturers use to structure and demonstrate this system and Notified Bodies commonly reference it during conformity assessment under MDR Annex IX. But holding an ISO 13485 certificate is not an automatic legal requirement for every device class. What MDR Article 10 requires is a QMS appropriate to the device’s risk and the manufacturer’s size and activity. But ISO 13485 is simply the most widely accepted way of meeting that requirement in a form Notified Bodies and authorities recognise.
Medical Device Labelling Requirements in Finland
Start with the general MDR labelling rules in Article 10, Article 20, and Annex I. Finland Medical Device Labelling Requirements build on top of that base, adding a national language layer through the Medical Devices Act.
Some elements don’t change no matter which EU country a device is sold in. CE marking, manufacturer information, Authorized Representative details where relevant, UDI, warnings, and symbols all apply the same way in Finland as anywhere else, as per Annex I.
Language is where Finland actually diverges, and it doesn’t work the same way for every device category.
Fimea’s official guidance on national language requirements, drawn from Section 5 of the Medical Devices Act (719/2021), breaks down as follows:
- For professional-use devices, the instructions for use can be in Finnish, Swedish, or English. It’s the manufacturer’s choice.
- Consumer devices work differently. Anything necessary for safe use has to appear in both Finnish and Swedish, and it’s up to the manufacturer’s own risk assessment to decide what counts as necessary.
- Home tests get the strictest treatment. Both Finnish and Swedish are mandatory, and there’s no English-only route available here.
This means a professional-use Class IIa device and a consumer home test can carry genuinely different language obligations. Treating all Finnish labelling as a single uniform rule is a mistake worth avoiding.
Registration Timelines for Medical Devices in Finland
Timing depends on which process is being measured.
- CE marking preparation, Notified Body assessment, technical documentation and clinical evaluation timelines follow the general MDR process and vary by device class and Notified Body workload; none of this is Finland-specific.
- Fimea’s registration process itself runs in two stages, with the operator first registering and receiving an Actor ID/SRN or CERE reference number, then registering its devices under that identifier.
- Fimea publishes estimated processing times for various services on its Estimated processing times page, which is the source to check for the specific procedure in question at the time of application.
Medical Device Registration Costs in Finland
Fimea publishes its fee schedule under the Decree on fees chargeable by the Finnish Medicines Agency (Decree 1344/2025, in force until 31 December 2026) and Section 50 of the Medical Devices Act. Registration is mandatory, and the fees below are current at the time of writing.
First registration fee: A one-time fee of €355, applicable to manufacturers, authorised representatives, importers, certain distributors, and other relevant operators.
Annual supervision fee, based on the number of devices notified by the operator:
| Number of Devices | Annual Supervision Fee |
| Up to 10 | €500 |
| 11 to 50 | €1,000 |
| 51 to 100 | €2,000 |
| 101 to 500 | €4,000 |
| More than 500 | €6,000 |
Importers pay a flat annual supervision fee of €500, sterilisation service providers pay €1,000 and distributors are liable to pay €500.
Classification decisions: €2,240 for a decision on the Act’s application under MDR Article 4, and €560 for a classification decision under MDR Article 51.
Certificates of free sale: €170 for a standard export certificate, €340 for expedited delivery within two weeks.
Beyond Fimea’s own charges, manufacturers should budget separately for Notified Body fees, translation costs, testing, and any regulatory consulting support.
Import Requirements for Medical Devices in Finland
Finland Medical Device Import Requirements are at the intersection of MDR importer obligations and general Finnish customs procedure, and the two should be kept separate in planning.
On the regulatory side, MDR Article 13 sets out importer obligations, including:
- Verifying that the device carries a valid CE mark
- Confirming that the manufacturer has appointed an Authorized Representative where required
- Checking that labelling and IFU meet applicable requirements, including Finland’s language rules
- Maintaining a register of complaints, non-conforming devices, and recalls
Importers established in Finland fall within Fimea’s registration obligation and must notify Fimea of their operation.
On the customs side, physical importation into Finland is a Finnish Customs (Tulli) matter, separate from Fimea’s device-conformity role. Tariff classification, VAT treatment and customs clearance procedures fall outside what Fimea publishes, and manufacturers or importers should confirm those specifics directly through Finnish Customs’ own official guidance.
PMS Requirements in Finland
Post-Market Surveillance (PMS) is an ongoing manufacturer obligation under the EU MDR and it continues after CE marking and after Finnish market entry, not just up to the point of sale.
Fimea’s guidance sets out the PMS system and plan requirements, and the reports manufacturers must prepare, in line with MDR Articles 83 to 92. Core elements include:
- A PMS system and PMS plan proportionate to device risk
- PMS reports for lower-risk devices and Periodic Safety Update Reports (PSURs) for higher-risk devices
- Serious incident reporting and trend reporting under MDR Articles 87 and 88
- Field Safety Corrective Actions where a safety issue requires market-level action
Incident reporting requirements depend on the regulatory basis under which the device was placed on the market. Devices compliant with the MDR or IVDR follow the reporting procedure under those Regulations, while older “legacy” devices placed on the market under the previous Directives follow a separate procedure recognised by Fimea. Applicable timeframe depends on incident severity and device classification under MDR Articles 87 and 88.
Fimea is the receiving authority for these reports inside Finland, alongside its role in maintaining the CERE and EUDAMED registrations that keep operator contact details current for vigilance purposes.
Conclusion
Finland operates inside the EU MDR and IVDR system, and CE marking remains the foundation of market access. But CE marking is not the finish line for Finland specifically. Fimea plays an active role through the CERE and EUDAMED registration obligation and ongoing supervision. Economic operator obligations, Finnish and Swedish language requirements for labelling and post-market surveillance duties all need to be checked against current official sources before a device goes live in this market. None of this replaces the underlying MDR work.
If you need support with medical device registration, CE marking, technical documentation, Fimea requirements or EU regulatory market access, reach out to the experts at Artixio for guidance tailored to your product and Finnish market entry goals.
FAQs
Q1. Is medical device registration required in Finland?
Yes. Beyond CE marking, operators established in Finland, including manufacturers, authorised representatives, importers, and certain distributors, must notify Fimea of their operations and devices through the CERE or EUDAMED register before the device is sold or made available.
Q2. Does Finland require CE marking for medical devices?
Yes. Medical Device CE Marking Finland is required under the EU MDR (or IVDR, for in vitro diagnostics) to place a device on the market anywhere in the EU, Finland included.
Q3. What is Fimea’s role in medical device registration?
Fimea is Finland’s national competent authority. It maintains the national CERE register, oversees Finnish operators’ EUDAMED registrations, issues classification decisions and derogations, sets and collects registration and supervision fees, and receives incident and vigilance reports.
Q4. Do non-EU medical device manufacturers need an EC REP in Finland?
Non-EU manufacturers need an EU Authorized Representative under MDR Article 11 to access the EU market, Finland included. This is an EU-level requirement, not a Finland-specific one.
Q5. What are the Finland Medical Device Registration Fees?
A one-off first registration fee of €355 per operator, plus an annual supervision fee ranging from €500 to €6,000 depending on device volume (or a flat €500 for importers and distributors, €1,000 for sterilisation providers). Additional fees apply for classification decisions, derogations and certificates of free sale.
